Nisa Investment Advisors, LLC Invitae Corp Transaction History

Nisa Investment Advisors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$0.42 - $0.72 $146 - $250	348 New	348 $0
Q1 2023 May 02, 2023	SELL	$1.2 - $2.73 $10,080 - $22,932	-8,400 Reduced 84.85%	1,500 $2,000
Q4 2022 Feb 02, 2023	BUY	$1.71 - $3.61 $14,364 - $30,324	8,400 Added 560.0%	9,900 $18,000
Q3 2022 Nov 07, 2022	BUY	$1.9 - $8.63 $893 - $4,056	470 Added 45.63%	1,500 $4,000
Q2 2022 Aug 03, 2022	SELL	$2.13 - $9.01 $66,882 - $282,914	-31,400 Reduced 96.82%	1,030 $3,000

Q1 2022 Apr 29, 2022	BUY	$6.28 - $15.59 $152,290 - $378,057	24,250 Added 296.45%	32,430 $258,000
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $5,439 - $10,607	-370 Reduced 4.33%	8,180 $92,000
Q3 2021 Oct 18, 2021	BUY	$24.31 - $33.6 $188,402 - $260,400	7,750 Added 968.75%	8,550 $243,000
Q2 2021 Aug 06, 2021	SELL	$26.09 - $40.4 $86,097 - $133,320	-3,300 Reduced 80.49%	800 $27,000
Q4 2020 Jan 25, 2021	BUY	$39.09 - $57.4 $7,427 - $10,906	190 Added 4.86%	4,100 $171,000
Q3 2020 Oct 20, 2020	BUY	$28.43 - $44.67 $82,447 - $129,543	2,900 Added 287.13%	3,910 $169,000
Q2 2020 Jul 27, 2020	BUY	$11.71 - $30.29 $3,747 - $9,692	320 Added 46.38%	1,010 $31,000
Q1 2020 Apr 17, 2020	BUY	$7.64 - $27.5 $687 - $2,475	90 Added 15.0%	690 $9,000
Q3 2019 Oct 17, 2019	BUY	$18.85 - $27.5 $2,827 - $4,125	150 Added 33.33%	600 $12,000
Q1 2019 Apr 17, 2019	BUY	$10.65 - $25.75 $4,792 - $11,587	450 New	450 $11,000
Q4 2018 Jan 17, 2019	SELL	$9.26 - $16.38 $926,000 - $1.64 Million	-100,000 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$7.54 - $18.31 $754,000 - $1.83 Million	100,000 New	100,000 $1.67 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.